// App-Quantinova.ai

: Comparison of Rivaroxaban with Argatroban in Heparin Induced Thrombocytopenia Using Historical Controls : A Case-Control Study

Researchers

Presenter

  • Vivek Suresh Modi

Principal Investigators

  • Karan Jatwani

  • Sridevi Rajeeve

  • Gaurav Kakked

  • Hardikumar Patel

  • Dhrubajyoti Bandyopadhyay

  • Siva Krishna Mannem

Medical Centers

  • Internal Medicine, Mount Sinai West- St. Luke's Hospital Center, New York, NY

  • Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital, New York, NY

  • Icahn School of Medicine at Mount Sinai St Luke's Roosevelt Hospital, New York, NY

  • Mount Sinai West-St. Luke's Hospital Center, new york, NY

  • Virginia Mason Memorial- Yakima Memorial hospital, Yakima, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Serotonin

  • Platelet count

Drug/Treatment

  • rivaroxaban

  • Argatroban

  • Heparin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved